NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Amarin Corporation plc (NASDAQ: AMRN)

 
AMRN Technical Analysis
5
As on 29th Nov 2024 AMRN STOCK Price closed @ 0.51 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.98 & Strong Sell for SHORT-TERM with Stoploss of 1.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AMRNSTOCK Price

Open 0.50 Change Price %
High 0.51 1 Day 0.02 4.08
Low 0.48 1 Week 0.02 4.08
Close 0.51 1 Month -0.07 -12.07
Volume 670355 1 Year -0.68 -57.14
52 Week High 1.43 | 52 Week Low 0.48
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 138.25 2.15%
LMDX 0.02 0.00%
MARA 27.42 1.86%
OPTT 0.50 35.14%
PONO 1.72 2.38%
TELL 1.00 0.00%
SMCI 32.64 -6.93%
BTB 0.03 0.00%
TWKS 4.47 -0.45%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
DBVT 3.90 539.34%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
CFFEW 0.11 120.00%
 
NASDAQ USA Top Losers Stocks
XOSWW 0.00 -100.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
APLT 2.03 -76.31%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
MILEW 0.06 -53.85%
OCAXW 0.01 -50.00%
LOTZW 0.01 -50.00%
 
 
AMRN
Daily Charts
AMRN
Intraday Charts
Whats New @
Bazaartrend
AMRN
Free Analysis
 
AMRN Important Levels Intraday
RESISTANCE0.57
RESISTANCE0.55
RESISTANCE0.54
RESISTANCE0.53
SUPPORT0.49
SUPPORT0.48
SUPPORT0.47
SUPPORT0.45
 
AMRN Forecast December 2024
4th UP Forecast1.3
3rd UP Forecast1.05
2nd UP Forecast0.89
1st UP Forecast0.73
1st DOWN Forecast0.29
2nd DOWN Forecast0.13
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.28
 
AMRN Weekly Forecast
4th UP Forecast0.78
3rd UP Forecast0.69
2nd UP Forecast0.64
1st UP Forecast0.59
1st DOWN Forecast0.43
2nd DOWN Forecast0.38
3rd DOWN Forecast0.33
4th DOWN Forecast0.24
 
AMRN Forecast2024
4th UP Forecast2.49
3rd UP Forecast1.86
2nd UP Forecast1.46
1st UP Forecast1.07
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.44
3rd DOWN Forecast-0.84
4th DOWN Forecast-1.47
 
 
AMRN Other Details
Segment EQ
Market Capital 1846060416.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AMRN Address
AMRN
 
AMRN Latest News
 
Your Comments and Response on Amarin Corporation plc
 
AMRN Business Profile
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Grand Canal Docklands, Dublin, Ireland, 2
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service